Match tier Institution-verified
Presence Current · Arkansas
Last published 2026
Sources Institutional record
Refreshed 2026-10-09

Elena Ambrogini

Sourced from institutional research profiles (UAMS TRI or ARA).

Federal Grant PI High Impact

Associate Professor

Also affiliated: University of Pisa (2002–2009); United States Department of Veterans Affairs (2024); University of Arkansas Medical Center (2024); Veterans Health Administration (2024); Central Arkansas Veterans Healthcare System (2009–2026); John L. McClellan Memorial Veterans Hospital (2024); Azienda Ospedaliera Universitaria Pisana (2005)

26 h-index 144 pubs 4,108 cited

  • Female
  • Humans
  • Animals
  • Mice
  • Male
  • Osteoblasts
  • Middle Aged
  • Bone Density
  • Aged
  • Bone and Bones
  • Osteogenesis
  • Adult
  • Apoptosis
  • Oxidative Stress
  • Signal Transduction

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Elena Ambrogini's research focuses on the molecular mechanisms underlying bone health and disease, particularly investigating the roles of oxidative stress and hormonal signaling in skeletal homeostasis. Her work has explored the impact of factors such as glucocorticoids, tumor necrosis factor α, and estrogen receptor-α on osteoblasts and osteoclasts.

Ambrogini has led investigations into the protective effects of FoxO-mediated defense against oxidative stress in osteoblasts, which has been shown to be indispensable for skeletal homeostasis in mice. Her research also examines how increased lipid oxidation contributes to oxidative stress and diminishes Wnt protein signaling in the skeleton. She received federal funding from the NIH for her project "Antibodies against Oxidized Phospholipids and Osteoporosis," serving as the Principal Investigator.

With an h-index of 26 and over 4,100 citations from 144 publications, Ambrogini is recognized as a highly cited researcher. She has a history of collaboration with researchers at the University of Arkansas for Medical Sciences, including Japneet Kaur, Aric Anloague, Sharmin Khan, and Charles A. O’Brien, with whom she shares numerous publications. Ambrogini leads a research group and has recently been active in research.

Metrics

  • h-index: 26
  • Publications: 144
  • Citations: 4,108

Positions

  • Associate Professor 2023–present
    University of Arkansas for Medical Sciences Orthopedics and Rehabilitation Institutional directory
  • Director of the Division of Endocrinology and Metabolism 2021–present
    University of Arkansas for Medical Sciences Internal medicine ORCID
  • Staff Endocrinologist (part time appointment) 2021–present
    Central Arkansas Veterans Healthcare System Internal medicine- Endocrinology ORCID
  • Staff Endocrinologist (full time appointment) 2015–2021
    Central Arkansas Veterans Healthcare System Internal medicine ORCID

Selected Publications

  • Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Journal of Experimental & Clinical Cancer Research DOI OpenAlex
  • Deletion of the scavenger receptor Scarb1 in osteoblast progenitors and myeloid cells does not affect bone mass (2025)
    PLoS ONE DOI OpenAlex
  • Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition (2025)
    Experimental Hematology and Oncology 3 citations DOI OpenAlex
  • Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial (2025)
    Endocrine 7 citations DOI OpenAlex
  • Deletion of the scavenger receptor Scarb1 in osteoblast progenitors and myeloid cells does not affect bone mass (2025)
    bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
  • Abstract 5099: Notch inhibition as a therapeutic approach to eliminate dormant cancer cells in multiple myeloma (2025)
    Cancer Research DOI OpenAlex
  • Plasma levels of anti phosphocholine IgM antibodies are negatively correlated with bone mineral density in humans (2025)
    Scientific Reports 1 citation DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1

VA Contact PI Oct 2019 - Dec 2027

Antibodies against Oxidized Phospholipids and Osteoporosis

Administered by Central Arkansas Veterans Healthcare System I01

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

  • Center for Musculoskeletal Disease Research (CMDR) NIH/Nat. Inst. of General Medical Sciences
  • Antibodies against oxidation-specific epitopes have an anabolic effect in murine bone Barton Endowment individual pilot study
  • Antibodies against oxidation specific epitopes affect glucose metabolism UAMS Tobacco Funds and Translational Research Institute
  • Role of subchondral bone osteocytes in post-traumatic osteoarthritis US Department of Defense
  • Role of Natural Antibodies Against Oxidation Specific Epitopes in Bone Homeostasis NIH
  • Atherosclerosis, osteoporosis, and innate immunity: a research career development plan UAMS Tobacco Funds and Translational Research Institute

Collaboration Network

204 Collaborators 84 Institutions 11 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics